Roswell Park researchers present a two-step, mechanism-based drug strategy at AACR 2026 that selectively targets cancers with ...

SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...

New research suggests hair loss may hinge on a fragile cellular balance during regeneration, where stem cells must survive a ...

Yifan Zhai, M.D., Ph.D., Chief Medical Officer of Ascentage Pharma, said, “These preclinical findings reflect our continued ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...

DNA robots are emerging as tiny programmable machines that could one day deliver drugs, hunt viruses, and build molecular-scale devices. By borrowing ideas from traditional robotics and combining them ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, disruption, and regulation of disease-associated genes.

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a precision tool, but is not perfect, and misplaced DNA edits can compromise ...

An identical twin commits a crime and leaves their DNA at the scene. Can DNA testing reveal which twin is the culprit? This question reportedly came up in a case in France last month, in which the DNA ...

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...

Most people alive today carry fragments of Neanderthal DNA in their genome. Now scientists are gaining a more intimate understanding of the ancient encounters that put it there. By Carl Zimmer One of ...